Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: February 2010

Chapter 6 - Preeclampsia

from Section 1 - Nutritional regulation and requirements for pregnancy and fetal growth

References

1. DaveyDA and MacgillivrayI, The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol (1988), 158:892–8.
2. Confidential Enquiries into Maternal and Child Health, Why Mothers Die 2000–2002. Report on confidential enquiries into maternal deaths in the United Kingdom (London: Royal College of Obstetricians and Gynaecologists, 2004).
3. FaragK, HassanI, and LedgerWL, Prediction of preeclampsia: can it be achieved?Obstet Gynecol Surv (2004), 59:464–82; quiz 485.
4. Confidential Enquiry into Stillbirths and Death in Infancy, 5th Annual Report. (London: Maternal and Child Health Research Consortium, 1998).
5. MccowanL, HardingJ, BarkerS, and FordC, Perinatal predictors of growth at six months in small for gestational age babies. Early Hum Dev (1999), 56:205–16.
6. BarkerDJ, GluckmanPD, GodfreyKM, HardingJE, OwensJF, and RobinsonJS, Fetal nutrition and cardiovascular disease in adult life. Lancet (1993), 341:938–41.
7. RedmanCW and SargentIL, Placental debris, oxidative stress and pre-eclampsia. Placenta (2000), 21:597–602.
8. RobertsJM and HubelCA, Is oxidative stress the link in the two-stage model of pre-eclampsia?Lancet (1999), 354:788–9.
9. RobertsJM and SpeerP, Antioxidant therapy to prevent preeclampsia. Semin Nephrol (2004), 24:557–64.
10. DiplockAT, CharleuxJL, Crozier-WilliG, KokFJ, and Rice-EvansC, et al., Functional food science and defence against reactive oxidative species. Br J Nutr (1998), 80(Suppl 1):S77–112.
11. RumboldA, DuleyL, CrowtherC, and HaslamR, Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev (2005), 4:CD004227.
12. ChappellLC, SeedPT, BrileyAL, KellyFJ, LeeR, HuntBJ, et al., Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet (1999), 354:810–6.
13. Poston, L, Briley, AL, Seed, PT, Kelly, FJ, and ShennanAH, VitaminC and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet (2006), 367:1145–54.
14. RumboldAR, CrowtherCA, HaslamRR, DekkerGA, and RobinsonJS, VitaminsC and E and the risks of preeclampsia and perinatal complications. N Engl J Med (2006), 354:1796–806.
15. StrattaP, CanaveseC, PorcuM, DoglianiM, TodrosT, GarboE, et al., Vitamin E supplementation in preeclampsia. Gynecol Obstet Investig (1994), 37:246–9.
16. GulmezogluAM, HofmeyrGJ, and OosthuisenMM, Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. BJOG (1997), 104:689–96.
17. MillerER 3rd, Pastor-BarriusoR, DalalD, RiemersmaRA, AppelLJ, and GuallarE, Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2005), 142:37–46.
18. SmedtsHP, de VriesJH, RakhshandehrooM, WildhagenMF, Verkleij-HagoortAC, SteegersEA, and Steegers-TheunissenRP, High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring. BJOG (2009), 116:416–23.
19. RamsayB, De BelderA, CampbellS, MoncadaS, and MartinJF, A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Investig (1994), 24:76–8.
20. GrunewaldC, KublickasM, CarlstromK, LunellNO, and NisellH, Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol (1995), 86:600–4.
21. NeriI, Di RenzoGC, CasertaG, GallinelliA, and FacchinettiF, Impact of the L-arginine/nitric oxide system in pregnancy. Obstet Gynecol Surv (1995), 50:851–8.
22. FacchinettiF, LongoM, PiccininiF, NeriI, and VolpeA, L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig (1999), 6:202–7.
23. FacchinettiF, Saade, GR Neri I, PizziC, LongoM, and VolpeA, L-arginine supplementation in patients with gestational hypertension: a pilot study. Hypertens Pregn (2007), 26:121–30.
24. EkerhovdE, Dietary supplementation with L-arginine in women with preeclampsia. Acta Obstet Gynecol Scand (2004), 83:871; author reply 872.
25. HofmeyrGJ, DuleyL, and AtallahA, Dietary calcium supplementation for prevention of preeclampsia and related problems: a systematic review and commentary. BJOG, 114:933–43.
26. LiuSY, XuYY, and ZhuJY (1994) [The effects of Salvia miltiorrhizae Bge and Ligustrazine on thromboxane A2 and prostacyclin in pregnancy induced hypertension]. Zhonghua Fu Chan Ke Za Zhi (2007), 29:648–50, 697.
27. ZhangJ, WuTX, and LiuGJ, Chinese herbal medicine for the treatment of pre-eclampsia. Cochrane Database Syst Rev (2006), (2):CD005126.
28. SecherNJ and OlsenSF, Fish-oil and pre-eclampsia. BJOG (1990), 97:1077–9.
29. SorensenJD, OlsenSF, PedersenAK, BorisJ, SecherNJ, and FitzgeraldGA, Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol (1993), 168:915–22.
30. OnwudeJL, LilfordRJ, HjartardottirH, StainesA, and TuffnellD, A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. BJOG (1995), 102:95–100.
31. OlsenSF, SecherNJ, TaborA, WeberT, WalkerJJ, and GluudC, Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG (2000), 107:382–95.
32. SmutsCM, HuangM, MundyD, PlasseT, MajorS, and CarlsonSE, A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol (2003), 101:469–79.
33. VillarJ, AbalosE, NardinJM, MerialdiM, and CarroliG, Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol (2004), 24:607–15.
34. MakridesM, DuleyL, and OlsenSF, Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane Database Syst Rev (2006), 3:CD003402.
35. LeedaM, RiyaziN, De VriesJI, JakobsC, Van GeijnHP, and DekkerGA, Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol (1998), 179:135–9.
36. IdeN, NelsonAB, and LauBH, Aged garlic extract and its constituents inhibit Cu(2+)-induced oxidative modification of low density lipoprotein. Plant Med (1997), 63:263–4.
37. BorekC, Antioxidant health effects of aged garlic extract. J Nutr (2001), 131:1010S–5S.
38. LauBH, Suppression of LDL oxidation by garlic. J Nutr (2001), 131:985S–8S.
39. DasI, KhanNS, and SoorannaSR, Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin (1995), 13:257–63.
40. MeherS and DuleyL, Garlic for preventing preeclampsia and its complications. Cochrane Database Syst Rev (2006b), 3:CD006065.
41. ZiaeiS, HantoshzadehS, RezasoltaniP, and Lamyian M, The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol (2001), 99:201–6.
42. ArosioP and LeviS, Ferritin, iron homeostasis, and oxidative damage. Free Radical Biol Med (2002), 33:457–63.
43. FangYZ, YangS, and WuG, Free radicals, antioxidants, and nutrition. Nutrition (2002), 18:872–9.
44. EntmanSS, KambamJR, BradleyCA, and CousarJB, Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia. Am J Obstet Gynecol (1987), 156:1169–73.
45. TakeiH, IizukaS, YamamotoM, TakedaS, YamamotoM, and ArishimaK, The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by N(omega)-nitro-L-arginine methyl ester. J Pharmacol Sci (2007), 104:319–28.
46. AltmanD, CarroliG, DuleyL, FarrellB, MoodleyJ, NeilsonJ, and SmithD, Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002), 359:1877–90.
47. MakridesM and CrowtherCA, Magnesium supplementation in pregnancy. Cochrane Database Syst Rev (2001), CD000937.
48. SibaiBM, VillarMA, and BrayE, (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol, 161:115–9.
49. HaiderBA and BhuttaZA, Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev (2006), 4:CD004905.
50. BowerD, The influence of dietary salt intake on pre-eclampsia. J Obstet Gynaecol Brit Commonw (1964), 71:123–5.
51. DuleyL, Henderson-SmartD, and MeherS, Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev (2005), 4:CD005548.
52. KnuistM, BonselGJ, ZondervanHA, and TreffersPE, Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial. BJOG (1998), 105:430–4.
53. SteegersEA, EskesTK, JongsmaHW, and HeinPR, Dietary sodium restriction during pregnancy; a historical review. Eur J Obstet Gynecol Reprod Biol (1991), 40:83–90.
54. KiilholmaP, PaulR, PakarinenP, and GronroosM, Copper and zinc in pre-eclampsia. Acta Obstet Gynecol Scand (1984), 63:629–31.
55. MukherjeeMD, SandsteadHH, RatnaparkhiMV, JohnsonLK, MilneDB, and StellingHP, Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. Am J Clin Nutr (1984), 40:496–507.
56. CaulfieldLE, ZavaletaN, ShankarAH, and MerialdiM, Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr (1998), 68:499S–508S.
57. JonssonB, HaugeB, LarsenMF, and HaldF (1996) Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand 75:725–9.
58. GoldenbergRL, CliverSP, BronsteinJ, CutterGR, AndrewsWW, and MennemeyerST. (1994) Bed rest in pregnancy. Obstet Gynecol 84:131–6.
59. SpinapoliceRX, FeldS, and HarriganJT, Effective prevention of gestational hypertension in nulliparous women at high risk as identified by the rollover test. Am J Obstet Gynecol (1983), 146:166–8.
60. HerreraJA, Nutritional factors and rest reduce pregnancy-induced hypertension and preeclampsia in positive roll-over test primigravidas. Int J Gynaecol Obstet (1993), 41:31–5.
61. MeherS and DuleyL, Rest during pregnancy for preventing preeclampsia and its complications in women with normal blood pressure. Cochrane Database Syste Rev (2006), 2:CD005939.
62. LaunerLJ, VillarJ, KestlerE, and De OnisM, The effect of maternal work on fetal growth and duration of pregnancy: a prospective study. BJOG (1990), 97:62–70.
63. HenriksenTB, HedegaardM, and SecherNJ, Standing and walking at work and birthweight. Acta Obstet Gynecol Scand (1995), 74:509–16.
64. MeherS and DuleyL, Exercise or other physical activity for preventing preeclampsia and its complications. Cochrane Database Syst Rev (2006), 2:CD005942.
65. YeoS, SteeleNM, ChangMC, LeclaireSM, RonisDL, and HayashiR, Effect of exercise on blood pressure in pregnant women with a high risk of gestational hypertensive disorders. J Reprod Med (2000), 45:293–8.
66. CarterJP, FurmanT, and HutchesonHR, Preeclampsia and reproductive performance in a community of vegans. South Med J (1987), 80:692–7.
67. SibaiBM, GordonT, ThomE, CaritisSN, KlebanoffM, McnellisD, and PaulRH, Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol (1995), 172:642–8.
68. SibaiBM, EwellM, LevineRJ, KlebanoffMA, EsterlitzJ, CatalanoPM, et al., Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet and Gynecol (1997), 177:1003–10.
69. O'BrienTE, RayJG, and ChanWS, Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology (2003), 14:368–74.
70. WolfM, KettyleE, SandlerL, EckerJL, RobertsJ, and ThadhaniR, Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol (2001), 98:757–62.
71. BodnarLM, NessRB, HargerGF, and RobertsJM, Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol (2005), 162:1198–206.
72. BodnarLM, NessRB, MarkovicN, and RobertsJM, The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol (2005), 15:475–82.